Weiming Tang

Nov 18, 2024 | sti.bmj.com | Nadja A. Vielot |Weiming Tang |Giovanni Villa

Published in STI: men who have sex with men frequently receive antibiotics despite negative STI testsThe Sydney Sexual Health Centre guidelines indicate immediate presumptive antibiotic treatment for men who have sex with men (MSM) with anogenital symptoms, in addition to laboratory-based three-site molecular testing for Chlamydia trachomatis (CT) and Neisseria gonorrhoea (GC).

May 31, 2024 | sti.bmj.com | Drieda Zace |Marina Daskalopoulou |Weiming Tang

Strategies for evaluating penicillin allergy in STI servicesOver-reporting of penicillin or beta-lactam allergy often complicates STI management.

Oct 17, 2023 | sti.bmj.com | Weiming Tang |Sonia F Raffe |Marina Daskalopoulou

Sitafloxacin for rectal and urogenital infections with quinolone-resistant Mycoplasma genitaliumSitafloxacin is a fourth-generation fluoroquinolone approved in Japan. An open-label prospective study evaluated sitafloxacin monotherapy (200 mg daily for 7 days) for treating rectal and urogenital infections in 180 men who have sex with men (MSM, 72 living with HIV), including 97 of 126 (77%) and 27 of 120 (23%) carrying strains with mutations in parC and gyrA, respectively.

Oct 17, 2023 | sti.bmj.com | Weiming Tang |Sonia F Raffe |Marina Daskalopoulou

Sitafloxacin for rectal and urogenital infections with quinolone-resistant Mycoplasma genitaliumSitafloxacin is a fourth-generation fluoroquinolone approved in Japan. An open-label prospective study evaluated sitafloxacin monotherapy (200 mg daily for 7 days) for treating rectal and urogenital infections in 180 men who have sex with men (MSM, 72 living with HIV), including 97 of 126 (77%) and 27 of 120 (23%) carrying strains with mutations in parC and gyrA, respectively.